According to Rx Savings Solutions, drugmakers raised list prices by an average of 6.6% in the first few weeks of this year on cancer, diabetes, and other prescription medicines. These increases are considered to be more moderate than those in past years, most likely because of the determined effort in Congress this year to pass some sort of legislation to lower the costs of prescription drugs.
The report said that about 150 drugmakers raised prices on 866 products in the U.S. through Jan. 20.
